Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Income from Non-Controlling Interests (2018 - 2021)

Historic Income from Non-Controlling Interests for Amphastar Pharmaceuticals (AMPH) over the last 4 years, with Q3 2021 value amounting to -$1.4 million.

  • Amphastar Pharmaceuticals' Income from Non-Controlling Interests fell 26155.61% to -$1.4 million in Q3 2021 from the same period last year, while for Dec 2021 it was -$1.2 million, marking a year-over-year decrease of 13266.26%. This contributed to the annual value of $1.2 million for FY2021, which is 28725.49% up from last year.
  • As of Q3 2021, Amphastar Pharmaceuticals' Income from Non-Controlling Interests stood at -$1.4 million, which was down 26155.61% from -$855000.0 recorded in Q2 2021.
  • Amphastar Pharmaceuticals' 5-year Income from Non-Controlling Interests high stood at $6.6 million for Q4 2019, and its period low was -$3.0 million during Q1 2019.
  • For the 4-year period, Amphastar Pharmaceuticals' Income from Non-Controlling Interests averaged around $354384.6, with its median value being $326000.0 (2019).
  • Per our database at Business Quant, Amphastar Pharmaceuticals' Income from Non-Controlling Interests skyrocketed by 456241.61% in 2019 and then plummeted by 26155.61% in 2021.
  • Quarter analysis of 4 years shows Amphastar Pharmaceuticals' Income from Non-Controlling Interests stood at -$149000.0 in 2018, then soared by 4562.42% to $6.6 million in 2019, then crashed by 83.56% to $1.1 million in 2020, then tumbled by 229.19% to -$1.4 million in 2021.
  • Its last three reported values are -$1.4 million in Q3 2021, -$855000.0 for Q2 2021, and $1.1 million during Q1 2021.